In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
.jpg?w=545&itok=iTMFQxrU "EPR-Logo-Thumbnail-(1)")
Using RWE in rare disease drug development: effective innovations with historical controls
With a growing number of therapies under development for rare diseases, William Maier discusses how real-world evidence can be effectively used as a historical control, overcoming challenges presented in clinical development.
-
Robotic Process Automation: Recruiting bots to accelerate clinical trials
Ronan Fox, Senior Vice President of Applied Digital Solutions, contributes his views on the increasing use of RPA in clinical trials.
-
Redefining CRO sourcing model terminology to optimise outsourcing strategies
Samir Shah, President, Strategic Solutions at ICON contributes to this Applied Clinical Trials article discussing the compelling need for new terminology for sourcing models in the CRO industry.
Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication of MultiMedia Healthcare, LLC. All rights reserved.
-
Embedding the patient point of view in everything you do
Rachel Ballinger, Patient Centred Outcomes Principal, shares the importance of using positive language when speaking with study participants.
-
Considerations for vaccine efficacy trials targeting emerging infectious diseases
Following the COVID-19 pandemic, Shelley McLendon outlines what lessons must be learned to prevent future other emerging infectious diseases developing on a similar scale.
This article is taken from European Biopharmaceutical Review October 2022, pages 16-18. Samedan Ltd
-
Elite stock: ICON sails through trials with top manager
CFO Brendan Brennan outlines what will drive growth at ICON in his interview with Citywire.
-
Supporting reimbursement decisions with data from external control arms
Data is at the heart of every decision made by CROs, and so can have significant legal and financial implications. In this article ICON experts weigh in on maximising the efficacy of data and ensuring the scientific rigour HTAs expect.
This article is taken from European Pharmaceutical Contractor, August 2022, pages 52-55. Samedan Ltd
-
Pharmacovigilance outsourcing: Ensuring a positive experience
Karen Johnstone and Sabine Richter discuss current outsourcing practices and tips for selecting a service provider to ensure a successful relationship.
-
Longitudinal qualitative research - Capturing the patient voice; enhancing patient centricity
Outcomes researchers Alexia Marrel and Sally Lanar share insights on longitudinal qualitative research - what it is, when and how it can be used and the key factors for success when using this type of research.
-
Nominations now open for ‘Company of the Year’ Award 2022
This article features commentary from CEO Steve Cutler about ICON being awarded 2021 Company of the Year.
.jpg?w=340&itok=WCOBfDtB "EPR-Logo-Thumbnail-(1)"){kind=icon}
